# Teg interpretation pdf **<br>Rating: 4.8 / 5 (4227 votes)<br>Downloads: 1045<br><br><a href="https://nafo.calendario2023.es/NFNJp8?keyword=teg+interpretation+pdf">CLICK HERE TO DOWNLOAD</a>**<br><br><br><br><br><br><br><br><br><br> TEG shows the interaction of platelets with the coagulation cascade (aggregation, clot strengthening, fibrin cross-linking and fibrinolysis) Verify correction of pH, temperature and hypocalcemia. Describe the normal/abnormal dynamic clotting parameters of Thromboelastography (TEG) and propose treatment using an algorithm. – TEG is abnormal. If the patient has ESRD, transfuse ddAVP. K – TEG is abnormal. Transfuse FFP, platelets and cryo. If the patient has ESRD, transfuse ddAVP. The patient is either thrombocytopenic or the platelets are dysfunctional. Implement TEG into a Trauma Center. Identify specific trauma patient populations at great risk for hemorrhagic shock and pathophysiology of hemorrhage/Trauma Induced Görlinger K et al. Clotting start time and clot formation rate are normal, but the clot is weak. Br J Anaesth INTERPRETATION OF VISCOELASTIC TEST RESULTS Viscoelastic testing results in the formation of a trace of clot strength against time, from which multiple variables can be Rapid TEG (r-TEG) utilizes tissue factor instead of the kaolin-cephalin reagent to activate blood coagulation. Because tissue factor triggers the extrinsic coagulation pathway, which involves a smaller number of coagulation factors, the test can be performed faster than conventional TEG OVERVIEW. Transfuse FFP and transfuse platelets. Transfuse platelets. Correct pH, temperature and Calcium if abnormal. Fast interpretation of thromboelastometry in non-cardiac surgery: reliability in patients with hypo-, normo-, and hypercoagulability. Clinical application of TEG began in the s with the advent of liver transplantation Learning Objectives. Strategize treatment options involving actual cases of hemorrhage Clotting start time is delayed and clot is weak. Clotting start time is delayed and the clot is weak. L, M, O – TEG is abnormal PDF. Thromboelastography (TEG) is a diagnostic assay to measure patients’ coagulation profiles and guide management with transfusions and hemostatic therapies. – TEG is abnormal. – TEG is abnormal Analysis ComparisonTEG or ROTEM versus SLT-guided transfusion, OutcomePatients receiving plateletsAnalysis ComparisonTEG or ROTEM versus Learning Objectives. Thromboelastography (TEG) is a viscoelastic hemostatic assay that measures the global viscoelastic properties of whole blood clot formation under low shear stress. TEG was first developed in by Helmut Hartert at the University of Heidelberg (1).